The role of media and the internet on vaccine adverse event reporting: A case study of human papillomavirus vaccination

Journal of Adolescent Health

Volumn 54, Issue 3, 2014, Pages 289-295

  Eberth, Jan M ^a,b   Kline, Kimberly N ^a,b   Moskowitz, David A ^c   Montealegre, Jane R ^d,e   Scheurer, Michael E ^e  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Internet; Mass media; Meningococcal vaccines; Newspapers; Papillomavirus vaccines; Vaccine Adverse Event Reporting System (VAERS)

Indexed keywords

INTERNET; MASS MEDIA; MENINGOCOCCAL VACCINES; NEWSPAPERS; PAPILLOMAVIRUS VACCINES; VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS);

ADOLESCENT; BIBLIOMETRICS; HUMANS; INTERNET; JOURNALISM, MEDICAL; LINEAR MODELS; MASS MEDIA; MENINGOCOCCAL VACCINES; NEWSPAPERS; PAPILLOMAVIRUS VACCINES; SEARCH ENGINE; UNITED STATES;

EID: 84894505534     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2013.09.005     Document Type: Article

References (32)

1. B. Romanowski Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines Hum Vaccines 7 2011 161 169
2. S.E. Gollust, A.F. Dempsey, and P.M. Lantz et al. Controversy undermines support for state mandates on the human papillomavirus vaccine Health Affair 29 2010 2041 2046
3. National Conference of State Legislatures. HPV vaccine. Available at: http://www.ncsl.org/issues-research/health/hpv-vaccine-state-legislation-and- statutes.aspx. Accessed July 8, 2013.
4. Office of the Governor Rick Perry. Relating to the immunization of young women from the cancer-causing human papillomavirus. Document RP652007. Available at: http://governor.state.tx.us/news/executive-order/3455/. Accessed April 5, 2013.
5. N. Abdelmutti, and L. Hoffman-goetz Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil in North American news magazines J Cancer Educ 25 2010 451 456
6. B.A. Slade, L. Leidel, and C. Vellozi et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine JAMA 302 2009 750 757
7. J.C.P. Weber Epidemiology in the United Kingdom of adverse drug reactions from non-steroidal anti-inflammatory drugs Side-effects of anti-inflammatory drugs, inflammation and drug therapy series Vol. 1 1987 Springer Netherlands The Netherlands 27 35
8. W. Zhou, V. Pool, and J.K. Iskander et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001 MMWR Surveill Summ 52 2003 1 24
9. B.J. Kelly, A.E. Leader, and D.J. Mittermaier et al. The HPV vaccine and the media: How has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Educ Couns 77 2009 308 313
10. L.K. Ball, G. Evans, and A. Bostrom Risky business: Challenges in vaccine risk communication Pediatrics 101 1998 453 458
11. R.T. Chen, S.C. Rastogi, and J.R. Mullen et al. The Vaccine Adverse Event Reporting System (VAERS) Vaccine 12 1994 542 552
12. Vaccine Adverse Event Reporting System. About the VAERS Program. Available at: http://vaers.hhs.gov/about/index. Accessed July 18, 2013.
13. Notice to readers: Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine MMWR Morb Mortal Wkly Rep 56 2007 794 795
14. L.E. Markowitz, E.F. Dunne, and M. Saraiya et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 56 2007 1 24
15. L.S. Aiken, and S.G. West Multiple regression: Testing and interpreting interactions 1991 Sage Thousand Oaks (CA)
16. M.E. Sobel Asymptotic confidence intervals for indirect effects in structural equation models Sociol Methodol 13 1982 290 312
17. C. Calloway, C.M. Jorgensen, M. Saraiya, and J. Tsui A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005 J Womens Health 15 2006 803 809
18. J. Quintero Johnson, C. Sinean, and A.M. Scott Exploring the presentation of news information about the HPV vaccine: A content analysis of a representative sample of U.S. newspaper articles Health Commun 26 2011 491 501
19. M.A. Habel, N. Liddon, and J.E. Stryker The HPV vaccine: A content analysis of online news stories J Womens Health 18 2009 401 407
20. J. Keelan, V. Pavri, R. Balakrishnan, and K. Wilson An analysis of the human papilloma virus vaccine debate on MySpace blogs Vaccine 28 2010 1535 1540
21. X. Nan, and K. Madden HPV vaccine information in the blogosphere: How positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions Health Commun 27 2012 829 836
22. A. Kata Anti-vaccine activists, Web 2.0, and the postmodern paradigm - An overview of tactics and tropes used online by the anti-vaccination movement Vaccine 30 2012 3778 3789
23. C. Betsch, N.T. Brewer, and P. Brocard et al. Opportunities and challenges of Web 2.0 for vaccination decisions Vaccine 30 2012 3723 3818
24. H.O. Witteman, and B.J. Zikmund-Fisher The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate Vaccine 30 2012 3734 3740
25. S.J. Bean Emerging and continuing trends in vaccine opposition website content Vaccine 29 2011 1874 1880
26. R.K. Zimmerman, R.M. Wolfe, and D.E. Fox et al. Vaccine criticism on the World Wide Web J Med Internet Res 7 2005 e17
27. R.M. Wolfe, L.K. Sharp, and M.S. Lipsky Content and design attributes of antivaccination web sites JAMA 287 2002 3245
28. Orac. Some post-holiday antivaccine "science." ScienceBlogs.com. Available at: http://scienceblogs.com/insolence/2012/12/26/ some-post-holiday-antivaccine-science/. Accessed March 27, 2013.
29. Gavura S. Gold mine or dumpster dive? A closer look at adverse event reports. Science Based Medicine. Available at: http://www.sciencebasedmedicine. org/index.php/gold-mine-or-dumpster-dive-a-closer-look-at-adverse-event-reports/ #more-20622. Accessed March 27, 2013.
30. Sanofi Pasteur. 284 Menactra, No. LE5917. 2011. U.S. Food and Drug Administration. Available at: http://www.fda.gov/downloads/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM131170.pdf. Accessed July 18, 2013.
31. Merck & Co., Inc. Gardasil, No. 9883616. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ UCM111263.pdf. Accessed July 18, 2013.
32. S. Stokley, A. Cohn, and C. Dorell et al. Adolescent vaccination coverage levels in the United States: 2006-2009 Pediatrics 128 2011 1078 1086